These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 1839059

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Degradation kinetics of gonadorelin in aqueous solution.
    Hoitink MA, Beijnen JH, Bult A, van der Houwen OA, Nijholt J, Underberg WJ.
    J Pharm Sci; 1996 Oct; 85(10):1053-9. PubMed ID: 8897270
    [Abstract] [Full Text] [Related]

  • 4. Formulation of vaccine adjuvant muramyldipeptides (MDP). 2. The thermal reactivity and pH of maximum stability of MDP compounds in aqueous solution.
    Powell MF, Foster LC, Becker AR, Lee W.
    Pharm Res; 1988 Aug; 5(8):528-32. PubMed ID: 3244663
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Disposition of nafarelin acetate, a potent agonist of luteinizing hormone-releasing hormone, in rats and rhesus monkeys.
    Chu NI, Chan RL, Hama KM, Chaplin MD.
    Drug Metab Dispos; 1985 Aug; 13(5):560-5. PubMed ID: 2865103
    [Abstract] [Full Text] [Related]

  • 8. Isoelectric focusing and capillary zone electrophoretic studies using luteinizing hormone releasing hormone and its analog.
    Heit MC, McFarland A, Bock R, Riviere JE.
    J Pharm Sci; 1994 May; 83(5):654-6. PubMed ID: 8071815
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preparation and in vitro/in vivo evaluation of luteinizing hormone releasing hormone (LHRH)-loaded polyhedral and spherical/tubular niosomes.
    Arunothayanun P, Turton JA, Uchegbu IF, Florence AT.
    J Pharm Sci; 1999 Jan; 88(1):34-8. PubMed ID: 9874699
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Stability of gonadorelin and triptorelin in aqueous solution.
    Helm VJ, Müller BW.
    Pharm Res; 1990 Dec; 7(12):1253-6. PubMed ID: 2151342
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer.
    Sanders LM, Kell BA, McRae GI, Whitehead GW.
    J Pharm Sci; 1986 Apr; 75(4):356-60. PubMed ID: 2941563
    [Abstract] [Full Text] [Related]

  • 18. Radioimmunoassay of nafarelin ([ 6-(3-(2-naphthyl)-D-alanine)]-luteinizing hormone-releasing hormone) in plasma or serum.
    Nerenberg C, Foreman J, Chu N, Chaplin MD, Kushinsky S.
    Anal Biochem; 1984 Aug 15; 141(1):10-6. PubMed ID: 6238549
    [Abstract] [Full Text] [Related]

  • 19. Degradation kinetics of metronidazole in solution.
    Wang DP, Yeh MK.
    J Pharm Sci; 1993 Jan 15; 82(1):95-8. PubMed ID: 8429500
    [Abstract] [Full Text] [Related]

  • 20. Long-term stability of aqueous solutions of luteinizing hormone-releasing hormone assessed by an in vitro bioassay and liquid chromatography.
    Shi YF, Sherins RJ, Brightwell D, Gallelli JF, Chatterji DC.
    J Pharm Sci; 1984 Jun 15; 73(6):819-21. PubMed ID: 6376770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.